Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

• Main Authors: Tiago Torres (Author), Anne Sohrt Petersen (Author), Ulla Ivens (Author), Albert Bosch Vilaro (Author), John Stinson (Author), José Manuel Carrascosa (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...